Answer
May 13, 2026 - 08:37 AM
It acts as a dual agonist at glucagon and glucagon-like peptide-1 (GLP-1) receptors, aiming to reduce body weight by increasing energy expenditure and decreasing food intake, while improving glycemic control and liver health. Dual agonist activity may provide greater efficacy in weight loss and metabolic benefits compared to single-receptor drugs.
